Evidence map›Paper›PMID 38518449›Full record

ArticleJournal of the neurological sciences2024

Stroke occurrence by hypertension treatment status in Ghana and Nigeria: A case-control study.

Fred Stephen Sarfo, Osahon Jeffery Asowata, Onoja Matthew Akpa, Joshua Akinyemi, Kolawole Wahab, Arti Singh, Albert Akpalu, Priscilla Abrafi Opare-Addo, Akinkunmi Paul Okekunle, Godwin Ogbole and 28 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the neurological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Untreated and uncontrolled hypertension in Japanese patients with spontaneous intracerebral hemorrhage.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 17 institutions in 6 countries.

Fred Stephen SarfoDepartment of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Electronic address: stephensarfo78@gmail.com.
Osahon Jeffery AsowataDepartment of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Nigeria.
Onoja Matthew AkpaDepartment of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Nigeria; Preventive Cardiology Research Unit, Institute of Cardiovascular Diseases, College of Medicine, University of Ibadan, Nigeria.
Joshua AkinyemiPreventive Cardiology Research Unit, Institute of Cardiovascular Diseases, College of Medicine, University of Ibadan, Nigeria.
Kolawole WahabDepartment of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Arti SinghDepartment of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Albert AkpaluDepartment of Medicine, University of Ghana Medical School, Accra, Ghana.
Priscilla Abrafi Opare-AddoDepartment of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Akinkunmi Paul OkekunleDepartment of Food and Nutrition, Seoul National University, Seoul, Republic of Korea.
Godwin OgboleDepartment of Radiology, University of Ibadan, Nigeria.
Adekunle FakunleDepartment of Public Health, Osun State University, Osogbo, Nigeria.
Oladimeji AdebayoDepartment of Medicine, University of Ibadan, Nigeria.
Reginald ObiakoDepartment of Medicine, Ahmadu Bello University, Zaria, Nigeria.
Cynthia AkisanyaFederal Medical Centre, Abeokuta, Nigeria.
Morenkeji KomolafeDepartment of Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.
Taiwo OlunugaFederal Medical Centre, Abeokuta, Nigeria.
Innocent I ChukwuonyeFederal Medical Centre Umuahia, Abia state, Nigeria.
Godwin OsaigbovoJos University Teaching Hospital Jos, Nigeria.
Paul OlowoyoFederal Teaching Hospital, Ido-Ekiti Ado-Ekiti, Nigeria.
Phillip B AdebayoAga Khan University Dar es Salaam, Tanzania.
Carolyn JenkinsMedical University of South Carolina, Charleston, USA.
Abiodun BelloDepartment of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Ruth LaryeaDepartment of Medicine, University of Ghana Medical School, Accra, Ghana.
Phillip IbinayeDepartment of Medicine, University of Ibadan, Nigeria.
Olatundun OlalusiDepartment of Public Health, Osun State University, Osogbo, Nigeria.
Sunday AdeniyiDepartment of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Oyedunni ArulogunCollege of Medicine, University of Ibadan, Nigeria.
Okechukwu OgahDepartment of Medicine, University of Ibadan, Nigeria.
Abiodun AdeoyeDepartment of Medicine, University of Ibadan, Nigeria.
Dialla SamuelDepartment of Medicine, University of Ibadan, Nigeria.
Benedit Calys-TagoeDepartment of Medicine, University of Ghana Medical School, Accra, Ghana.
Hemant TiwariUniversity of Alabama at Birmingham, Birmingham, AL, USA.
Onyemelukwe ObiageliDepartment of Medicine, Ahmadu Bello University, Zaria, Nigeria.
Yaw MensahKorle Bu Teaching Hospital, Accra, Ghana.
Lambert AppiahDepartment of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Rufus AkinyemiDepartment of Medicine, University of Ibadan, Nigeria; Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria; Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Nigeria.
Bruce OvbiageleWeill Institute for Neurosciences, School of Medicine, University of California San-Francisco, USA.
Mayowa OwolabiPreventive Cardiology Research Unit, Institute of Cardiovascular Diseases, College of Medicine, University of Ibadan, Nigeria; Department of Medicine, University of Ibadan, Nigeria; Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Nigeria; Lebanese American University, Beirut, Lebanon. Electronic address: mayowaowolabi@yahoo.com.
University of Ibadan · NGKwame Nkrumah University of Science and Technology · GHUniversity of Ghana · GHUniversity of Ilorin Teaching Hospital · NGAhmadu Bello University · NGFederal Medical Centre · NGOsun State University · NGAga Khan University · TZEkiti State University · NGFederal Medical Centre · NGJos University Teaching Hospital · NGKorle Bu Teaching Hospital · GHMedical University of South Carolina · USObafemi Awolowo University · NGSeoul National University · KRUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · US

Funding

H3Africa Administrative Coordinating Centre: Enabling and Supporting Genomics and Health Research Capacity Building in AfricaU24HG009780 · NHGRI · UNIVERSITY OF CAPE TOWN · PI SKELTON, MICHELLE · 2017 to 2022
$4.8M
Stroke Investigative Research & Educational Network (SIREN)U54HG007479 · NHGRI · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2013 to 2017
$4.2M
CNV And Stroke (CaNVAS)R01NS114045 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI COLE, JOHN W. · 2020 to 2024
$2.6M
African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES)R01NS115944 · NINDS · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2020 to 2025
$2.2M
Systematic Investigation of Blacks with Stroke - Genomics (SIBS-Genomics) StudyR01NS107900 · NINDS · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2018 to 2021
$1.8M
Training Africans to Lead and Execute Neurological Trials & Studies (TALENTS)D43TW012030 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OVBIAGELE, BRUCE · 2021 to 2025
$1.2M
Growing Data-science Research in Africa to Stimulate Progress (GRASP)UE5HL172183 · NHLBI · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI FATUMO, SEGUN, OVBIAGELE, BRUCE · 2023 to 2025
$568k
African Neurobiobank for Precision Stroke Medicine - (ELSI) ProjectU01HG010273 · NHGRI · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI AKINYEMI, RUFUS OLUSOLA, ARULOGUN, OYEDUNNI SOLA · 2018 to 2022
$512k
Sub-Saharan Africa Conference on Stroke (SSACS) ConferenceR13NS115395 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI OVBIAGELE, BRUCE · 2020 to 2020
$50k
FIC NIH HHS D43 TW012030NHGRI NIH HHS U01 HG010273NHGRI NIH HHS U24 HG009780NHGRI NIH HHS U54 HG007479NHLBI NIH HHS UE5 HL172183NINDS NIH HHS R01 NS107900NINDS NIH HHS R01 NS114045NINDS NIH HHS R01 NS115944NINDS NIH HHS R13 NS115395
6 · The paper itself

Abstract

backgroundHypertension is preeminent among the vascular risk factors for stroke occurrence. The wide gaps in awareness, detection, treatment, and control rates of hypertension are fueling an epidemic of stroke in sub-Saharan Africa. PURPOSE: To quantify the contribution of untreated, treated but uncontrolled, and controlled hypertension to stroke occurrence in Ghana and Nigeria.

methodsThe Stroke Investigative Research and Educational Network (SIREN) is a case-control study across 16 study sites in Ghana and Nigeria. Cases were acute stroke (n = 3684) with age- and sex-matched stroke-free controls (n = 3684). We evaluated the associations of untreated hypertension, treated but uncontrolled hypertension, and controlled hypertension at BP of <140/90 mmHg with risk of stroke occurrence. We assessed the adjusted odds ratio and population-attributable risk of hypertension treatment control status associated with stroke occurrence.

resultsThe frequencies of no hypertension, untreated hypertension, treated but uncontrolled hypertension and controlled hypertension among stroke cases were 4.0%, 47.7%, 37.1%, and 9.2% vs 40.7%, 34.9%, 15.9%, and 7.7% respectively among stroke-free controls, p < 0.0001. The aOR and PAR (95% CI) for untreated hypertension were 6.58 (5.15-8.41) and 35.4% (33.4-37.4); treated but uncontrolled hypertension was 9.95 (7.60-13.02) and 35.9% (34.2-37.5); and controlled hypertension 5.37 (3.90-7.41) and 8.5% (7.6-9.5) respectively. Untreated hypertension contributed a PAR of 47.5% to the occurrence of intracerebral hemorrhage vs 29.5% for ischemic stroke. The aOR of untreated hypertension for stroke occurrence was 13.31 (7.64-23.19) for <50 years; 7.14 (4.51-11.31) for 50-64 years; and 3.48 (2.28-5.30) for 65 years or more.

conclusionThe contribution of untreated hypertension and treated but uncontrolled hypertension to stroke occurrence among indigenous Africans is substantial. Implementing targeted interventions that address gaps in hypertension prevention and treatment, involving the local population, healthcare providers, and policymakers, can potentially substantially reduce the escalating burden of strokes in Africa.

Indexed as

HypertensionStrokeCase-Control StudiesGhanaHumansNigeriaRisk FactorsAfricaHypertensionPreventionRisk factorsStroke

Identifiers

PMID38518449
PMCPMC11073807
OpenAlexW4392896388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.